Registered entities
REJUVENATE BIOMED
Reg. No. 0681.964.735Belgium
Innovation
3 patent families (1 granted) — focus: Human necessities; filing pace accelerating. Cited 217 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Social engagement
Social engagement: 3.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record; lead investors include Vesalius Biocapital III, Rejuveron Life Sciences.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Accelerator & incubator | 1 | 33% |
| Other / undisclosed | 1 | 33% |
Recent activity
2 Jul 2026
Event
BIO 2026
15 Jun 2026
Event
BIO2026
5 Jun 2026
Event
KFG2026